Meeting
2023 ASCO Annual Meeting
Estimated life-years gained and resultant cost savings from follow-up colonoscopy after a positive multi-target stool DNA (mt-sDNA) test for colorectal cancer screening in commercially insured and Medicare populations.
Authors
A. Mark Fendrick
University of Michigan, Ann Arbor, MI
A. Mark Fendrick , John B. Kisiel , Derek W. Ebner , Vahab Vahdat , A. Burak Ozbay , Chris Estes , Paul J. Limburg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6642)
DOI
10.1200/JCO.2023.41.16_suppl.6642
Abstract #
6642
Poster Bd #
134
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Comparison of simulated outcomes between stool- and blood-based colorectal cancer screening tests.
First Author: A. Fendrick
Poster
2024 ASCO Annual Meeting
A multi-center study for colorectal cancer early detection among patients with high-risk disease using a cell-free fragmentomics assay.
First Author: Jierong Chen
Poster
2023 ASCO Quality Care Symposium
Analysing the colorectal cancer screening patterns during the COVID-19 pandemic and their effects on patient outcomes.
First Author: Joshua Ling
Poster
2023 ASCO Quality Care Symposium
Potentially avoidable delays in diagnosis among patients with colorectal cancer: A population-based study.
First Author: Kano Amagai